Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Murray, P. Sonnenberg, A. Bester, G. Nelson, S. Shearer, J. R. Glynn (Johannesburg, South Africa; London, United Kingdom). Effect of time since seroconversion to HIV: rates and risks of recurrent tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 1596

Member's Comments

No comment yet.

Related content which might interest you: Treatment of latent tuberculosis infection: completion rates and adverse effects Source: Eur Respir J 2003; 22: Suppl. 45, 526s Year: 2003 Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area Source: Eur Respir J 2015; 46: 165-174 Year: 2015 The impact of HIV on tuberculosis recrudescence Source: Eur Respir J 2004; 24: Suppl. 48, 362s Year: 2004 Timing of relapse of tuberculosis in people with co-infection (HIV/TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Impact of adverse drug reactions on treatment interruption in TB patients with and without HIV coinfection Source: ISSN=ISSN 1810-6838, ISBN=, page=190 Year: 2006 The risk of tuberculosis disease among HIV infected patients after 2 years of follow up Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 HIV and TB: cost implications of rapid rises in a previously low incidence area Source: Eur Respir J 2004; 24: Suppl. 48, 196s Year: 2004 The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland Source: Eur Respir J 2005; 26: Suppl. 49, 425s Year: 2005 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Effect of smoking history on outcome of patients diagnosed with TB and HIV Source: Eur Respir J 2015; 45: 839-842 Year: 2015 Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-γ release assays Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 The risk of latent Mycobacterium tuberculosis infection in HIV seropositive children not BCG vaccinated Source: Eur Respir J 2005; 26: Suppl. 49, 424s Year: 2005 Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 HIV and multidrug-resistant tuberculosis: overlapping risk factors Source: Eur Respir J 2015; 45: 567-569 Year: 2015 Mutual impact of HIV infection on HIV/tuberculosis co-infection Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009